Ocular and systemic morbidity in a longitudinal cohort of Sjögren's syndrome

Research output: Contribution to journalArticle

Abstract

Purpose: To report vision-threatening ocular manifestations of primary Sjögren's syndrome (SS). Design: Retrospective review. Participants: Consecutive patients evaluated at an SS center between January 2007 and May 2011. Methods: Data collection was completed in March 2013. The 2002 American-European consensus criteria were used for diagnosis of SS. Main Outcome Measures: Frequency of extraglandular ocular findings and timing of their diagnosis relative to that of SS and dry eye were assessed. Results: One hundred sixty-three patients were included. Almost all patients (98%) had a history of dry eye for an average of 10.4 years (median, 7.9 years) before presentation. One or more extraglandular ocular manifestations were present in 40 patients (25%), and vision-threatening findings were present in 22 patients (13%). Twelve patients (55%) with a vision-threatening ocular finding did not have a diagnosis of SS at presentation. Sixty-eight patients (42%) had extraglandular systemic manifestations of SS. Patients with vision-threatening ocular findings were 3.9 times more likely to have systemic involvement (95% confidence interval, 1.4-11.0; P = 0.010). Peripheral neuropathy, interstitial nephritis, and vasculitis were more common in those with visionthreatening ocular findings compared with patients without (P <0.05 for all). Conclusions: These results from a tertiary referral-based cohort demonstrate that primary SS frequently is associated with ocular and systemic complications. Dry eye precedes these findings on average by 1 decade. Therefore, ophthalmologists should consider assessing for SS in patients with clinically significant dry eye.

Original languageEnglish (US)
Pages (from-to)56-61
Number of pages6
JournalOphthalmology
Volume122
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Morbidity
Eye Manifestations
Dry Eye Syndromes
Interstitial Nephritis
Peripheral Nervous System Diseases
Vasculitis
Consensus
Referral and Consultation
Outcome Assessment (Health Care)
Confidence Intervals

ASJC Scopus subject areas

  • Ophthalmology
  • Medicine(all)

Cite this

Ocular and systemic morbidity in a longitudinal cohort of Sjögren's syndrome. / Akpek, Esen K; Mathews, Priya; Hahn, Sarah; Hessen, Michelle; Kim, Jean; Grader Beck, Thomas; Birnbaum, Julius; Baer, Alan.

In: Ophthalmology, Vol. 122, No. 1, 01.01.2015, p. 56-61.

Research output: Contribution to journalArticle

@article{cbf1f517fa954b6ea3b7ed8cd710e4cb,
title = "Ocular and systemic morbidity in a longitudinal cohort of Sj{\"o}gren's syndrome",
abstract = "Purpose: To report vision-threatening ocular manifestations of primary Sj{\"o}gren's syndrome (SS). Design: Retrospective review. Participants: Consecutive patients evaluated at an SS center between January 2007 and May 2011. Methods: Data collection was completed in March 2013. The 2002 American-European consensus criteria were used for diagnosis of SS. Main Outcome Measures: Frequency of extraglandular ocular findings and timing of their diagnosis relative to that of SS and dry eye were assessed. Results: One hundred sixty-three patients were included. Almost all patients (98{\%}) had a history of dry eye for an average of 10.4 years (median, 7.9 years) before presentation. One or more extraglandular ocular manifestations were present in 40 patients (25{\%}), and vision-threatening findings were present in 22 patients (13{\%}). Twelve patients (55{\%}) with a vision-threatening ocular finding did not have a diagnosis of SS at presentation. Sixty-eight patients (42{\%}) had extraglandular systemic manifestations of SS. Patients with vision-threatening ocular findings were 3.9 times more likely to have systemic involvement (95{\%} confidence interval, 1.4-11.0; P = 0.010). Peripheral neuropathy, interstitial nephritis, and vasculitis were more common in those with visionthreatening ocular findings compared with patients without (P <0.05 for all). Conclusions: These results from a tertiary referral-based cohort demonstrate that primary SS frequently is associated with ocular and systemic complications. Dry eye precedes these findings on average by 1 decade. Therefore, ophthalmologists should consider assessing for SS in patients with clinically significant dry eye.",
author = "Akpek, {Esen K} and Priya Mathews and Sarah Hahn and Michelle Hessen and Jean Kim and {Grader Beck}, Thomas and Julius Birnbaum and Alan Baer",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.ophtha.2014.07.026",
language = "English (US)",
volume = "122",
pages = "56--61",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Ocular and systemic morbidity in a longitudinal cohort of Sjögren's syndrome

AU - Akpek, Esen K

AU - Mathews, Priya

AU - Hahn, Sarah

AU - Hessen, Michelle

AU - Kim, Jean

AU - Grader Beck, Thomas

AU - Birnbaum, Julius

AU - Baer, Alan

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Purpose: To report vision-threatening ocular manifestations of primary Sjögren's syndrome (SS). Design: Retrospective review. Participants: Consecutive patients evaluated at an SS center between January 2007 and May 2011. Methods: Data collection was completed in March 2013. The 2002 American-European consensus criteria were used for diagnosis of SS. Main Outcome Measures: Frequency of extraglandular ocular findings and timing of their diagnosis relative to that of SS and dry eye were assessed. Results: One hundred sixty-three patients were included. Almost all patients (98%) had a history of dry eye for an average of 10.4 years (median, 7.9 years) before presentation. One or more extraglandular ocular manifestations were present in 40 patients (25%), and vision-threatening findings were present in 22 patients (13%). Twelve patients (55%) with a vision-threatening ocular finding did not have a diagnosis of SS at presentation. Sixty-eight patients (42%) had extraglandular systemic manifestations of SS. Patients with vision-threatening ocular findings were 3.9 times more likely to have systemic involvement (95% confidence interval, 1.4-11.0; P = 0.010). Peripheral neuropathy, interstitial nephritis, and vasculitis were more common in those with visionthreatening ocular findings compared with patients without (P <0.05 for all). Conclusions: These results from a tertiary referral-based cohort demonstrate that primary SS frequently is associated with ocular and systemic complications. Dry eye precedes these findings on average by 1 decade. Therefore, ophthalmologists should consider assessing for SS in patients with clinically significant dry eye.

AB - Purpose: To report vision-threatening ocular manifestations of primary Sjögren's syndrome (SS). Design: Retrospective review. Participants: Consecutive patients evaluated at an SS center between January 2007 and May 2011. Methods: Data collection was completed in March 2013. The 2002 American-European consensus criteria were used for diagnosis of SS. Main Outcome Measures: Frequency of extraglandular ocular findings and timing of their diagnosis relative to that of SS and dry eye were assessed. Results: One hundred sixty-three patients were included. Almost all patients (98%) had a history of dry eye for an average of 10.4 years (median, 7.9 years) before presentation. One or more extraglandular ocular manifestations were present in 40 patients (25%), and vision-threatening findings were present in 22 patients (13%). Twelve patients (55%) with a vision-threatening ocular finding did not have a diagnosis of SS at presentation. Sixty-eight patients (42%) had extraglandular systemic manifestations of SS. Patients with vision-threatening ocular findings were 3.9 times more likely to have systemic involvement (95% confidence interval, 1.4-11.0; P = 0.010). Peripheral neuropathy, interstitial nephritis, and vasculitis were more common in those with visionthreatening ocular findings compared with patients without (P <0.05 for all). Conclusions: These results from a tertiary referral-based cohort demonstrate that primary SS frequently is associated with ocular and systemic complications. Dry eye precedes these findings on average by 1 decade. Therefore, ophthalmologists should consider assessing for SS in patients with clinically significant dry eye.

UR - http://www.scopus.com/inward/record.url?scp=84920743584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920743584&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2014.07.026

DO - 10.1016/j.ophtha.2014.07.026

M3 - Article

C2 - 25178806

AN - SCOPUS:84920743584

VL - 122

SP - 56

EP - 61

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 1

ER -